✦ LIBER ✦

Biochemical and molecular characterization of the novel BRAFV599Ins mutation detected in a classic papillary thyroid carcinoma

✍ Scribed by Moretti, S; Macchiarulo, A; De Falco, V; Avenia, N; Barbi, F; Carta, C; Cavaliere, A; Melillo, R M; Passeri, L; Santeusanio, F

Book ID: 110070469
Publisher: Nature Publishing Group
Year: 2006
Tongue: English
Weight: 306 KB
Volume: 25
Category: Article
ISSN: 0950-9232
DOI: 10.1038/sj.onc.1209448

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Genotyping of an Italian papillary thyro

Genotyping of an Italian papillary thyroid carcinoma cohort revealed high prevalence of BRAF mutations, absence of RAS mutations and allowed the detection of a new mutation of BRAF oncoprotein (BRAFV599Ins)

✍ Claudio Carta; Sonia Moretti; Lucia Passeri; Flavia Barbi; Nicola Avenia; Antoni 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 150 KB

Searching for RET/PTC rearrangements and

Searching for RET/PTC rearrangements and BRAF V599E mutation in thyroid aspirates might contribute to establish a preoperative diagnosis of papillary thyroid carcinoma

✍ R. Domingues; E. Mendonça; L. Sobrinho; M. J. Bugalho 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 158 KB

BRAFV600E mutation and p27kip1 expressio

BRAFV600E mutation and p27kip1 expression in papillary carcinomas of the thyroid ≤1 cm and their paired lymph node metastases

✍ Vito Rodolico; Daniela Cabibi; Giuseppe Pizzolanti; Pierina Richiusa; Nicola Geb 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 264 KB 👁 1 views

## Abstract ## BACKGROUND. __BRAF^V600E^__ mutation and p27^kip1^ expression have been introduced as novel indicators that may predict prognosis in different tumors, as well as in papillary thyroid carcinomas. ## METHODS. Tissue samples from 214 consecutive patients who underwent total or near‐t

Identification of a novel noncoding RNA

Identification of a novel noncoding RNA gene, NAMA, that is downregulated in papillary thyroid carcinoma with BRAF mutation and associated with growth arrest

✍ Heejei Yoon; Huiling He; Rebecca Nagy; Ramana Davuluri; Saul Suster; Daniel Scho 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 French ⚖ 793 KB

## Abstract In search of tumor suppressor genes in papillary thyroid carcinoma (PTC), we previously used gene expression profiling to identify genes underexpressed in tumor compared with paired unaffected tissue. While searching for loss of heterozygosity (LOH) in genomic regions harboring candidat

A novel de novo germ-line V292M mutation

A novel de novo germ-line V292M mutation in the extracellular region of RET in a patient with phaeochromocytoma and medullary thyroid carcinoma: functional characterization

✍ Maria D. Castellone; Antonella Verrienti; Deva Magendra Rao; Marialuisa Sponziel 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 251 KB

Identification of a novel somatic mutati

Identification of a novel somatic mutation in the RET proto-oncogene in a patient with sporadic medullary thyroid carcinoma

✍ Xavier Matias-Guiu; Elena Lagarda; Monica Calaf; Arturo Azpiroz; Alberto De Leiv 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 84 KB 👁 2 views

Duchenne muscular dystrophy (DMD) is an X-linked degenerative disorder of muscle, caused by gross rearrangements by the dystrophin gene in two-thirds of cases. The remaining one-third of patients may carry more subtle mutations that are difficult to detect because of the large size and complexity of